Home
Perceptive Advisors reported a 3.2% stake in Contineum Therapeutics CTNM · 699,486 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.2%
- Last report
- 7.5% · filed 25/05/15
- Shares held
- 699,486 sh
- Class
- Class A Common Stock, par value $0.001 per share
- Holder
- Perceptive Advisors
- Event date
- 25/06/30
- Filed
- 25/08/14
3.2% stake · below 5%
- Stake
- 3.2%
- Last report
- 7.5%
- Since last report
- −4.3pp
Contineum Therapeutics trades, last 26 weeks
What else happened in Contineum Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Perceptive Advisors's other 5% stake reports
- Perceptive Advisors
5% stakeKardigan
5% stakeKardigan
KARD
8.8% stake
8,254,144 sh
8.8% stake
Filed 10/01
- Perceptive Advisors
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
5.3% stake
5,536,629 sh
5.3% stake
Filed 09/23
- Perceptive Advisors
5% stakeImmatics
5% stakeImmatics
IMTX
7.6% stake
11,418,016 sh
7.6% stake
Filed 08/27
- Perceptive Advisors
5% stakeLeonaBio
5% stakeLeonaBio
LONA
19.99% stake
1,889,403 sh
19.99% stake
Filed 08/25
- Perceptive Advisors
5% stakeSolid Biosciences
5% stakeSolid Biosciences
SLDB
11.2% stake
12,046,579 sh
11.2% stake
Filed 08/14